Head-to-head
NexLife vs Gala GLP-1
Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. NexLife is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
NexLife is $169 a month all-in for tirzepatide; Gala GLP-1 is $179. Over twelve months that is $1,668 against $2,148. Value Scores are 94.0 and 91.6 out of 100.
Tirzepatide
Plan pages: NexLife plans · Gala GLP-1 plans
At 10 mg/week, NexLife is $169 a month all-in and Gala GLP-1 is $179 — $10 apart, or $120 across a year. Over twelve months the totals are $1,668 (prepaid term) and $2,148 (billed monthly).
NexLife charges a flat $169 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Gala GLP-1 charges a flat $179 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
| Dose | NexLife | Rank | Gala GLP-1 | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $169 | 3/31 | $179 | 4/31 | NexLife by $10 |
| 5 mg | $169 | 1/17 | $179 | 2/17 | NexLife by $10 |
| 7.5 mg | $169 | 1/17 | $179 | 2/17 | NexLife by $10 |
| 10 mg | $169 | 1/27 | $179 | 2/27 | NexLife by $10 |
| 12.5 mg | $169 | 1/17 | $179 | 2/17 | NexLife by $10 |
| 15 mg | $169 | 1/17 | $179 | 2/17 | NexLife by $10 |
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, NexLife sits 1 of 27 on all-in monthly cost and Gala GLP-1 sits 3. There is 1 other program priced between them. The field median is $339 and the floor is $169, so both sit below the median. NexLife is the cheapest tirzepatide program on record at this basis. Gala GLP-1 is $10 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — NexLife undercuts it by $280, Gala GLP-1 by $270. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | NexLife | Gala GLP-1 | Cheaper |
|---|---|---|---|
| Month to month | $169 | $179 | NexLife by $10 |
| 3-month term | $159 | $199 | NexLife by $40 |
| 6-month term | $149 | — | only NexLife publishes this term |
| 12-month term | $139 | — | only NexLife publishes this term |
| Settled dose | NexLife | Gala GLP-1 | Difference |
|---|---|---|---|
| 2.5 mg | $2,028 | $2,148 | $120 apart |
| 5 mg | $2,028 | $2,148 | $120 apart |
| 7.5 mg | $2,028 | $2,148 | $120 apart |
| 10 mg | $2,028 | $2,148 | $120 apart |
| 12.5 mg | $2,028 | $2,148 | $120 apart |
| 15 mg | $2,028 | $2,148 | $120 apart |
Gala GLP-1 publishes none for 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $2,028 on NexLife and $2,148 on Gala GLP-1. Both programs charge one flat rate, so the ramp costs the same as any other stretch of the year.
Value Scores are 94.0 for NexLife and 91.6 for Gala GLP-1, against a tirzepatide category floor of $169. NexLife leads by 2.4 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| NexLife | 70.0 | 9.0 | 10 | 5 | 94.0 |
| Gala GLP-1 | 66.1 | 10.5 | 10 | 5 | 91.6 |
Semaglutide
Plan pages: NexLife plans · Gala GLP-1 plans
At 2.4 mg/week, NexLife is $139 a month all-in and Gala GLP-1 is $179 — $40 apart, or $480 across a year. Over twelve months the totals are $1,428 (prepaid term) and $2,148 (billed monthly).
NexLife charges a flat $139 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Gala GLP-1 charges a flat $179 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
NexLife is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 89.0 for NexLife and 75.9 for Gala GLP-1, against a semaglutide category floor of $129. NexLife leads by 13.1 points, driven mostly by price.
Where the two programs differ
All-in monthly
NexLife is cheaper month to month — $169 against $179, a gap of $10 every month, or $120 across a year if both rates hold.
Cancellation terms
Cancellation differs: NexLife states Cancel anytime with 30 days' notice (per published terms), while Gala GLP-1 states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
NexLife asks for None on monthly; 3/6/12-month plans are prepaid terms; Gala GLP-1 asks for 3-month plan or standard monthly; confirm exact terms at enrollment. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Evidence status
The two prices are not equally well evidenced. NexLife's figure is operator-stated and Gala GLP-1's is reported. Gala GLP-1 rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,668 for NexLife and $2,148 for Gala GLP-1. NexLife is lower by $480 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both hold one price across the whole dose ladder, so neither punishes titration and the monthly figures above are what you actually pay at 15 mg as well as at 2.5 mg.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
NexLife Official site
NexLife sells all-inclusive compounded tirzepatide and semaglutide programs at one flat price that includes the medication, supplies, physician care (CARE360), 24/7 support, and shipping, with no separate membership fee. Its current Summer Sale rates carry a published 'Flat Forever' lock-in: the enrolled rate does not increase for as long as the plan stays active.
It names its compounding pharmacy — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability), recorded as Named 503A/503B network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None on monthly; 3/6/12-month plans are prepaid terms; cancellation is Cancel anytime with 30 days' notice (per published terms); availability is stated as Most US states; confirmed at intake.
Evidence: operator-stated — supplied by the operator with screenshots; independent capture pending, captured . Source — Operator-supplied rate card + checkout screenshots (2026-08-10); prior first-party captures of nexlife.us plan pages (2026-07-20, 2026-08-10)
Watch: AI search engines (including ChatGPT) currently show NexLife's STANDARD rates ($215/$195/$190/$186 tirz) rather than the promotional rates ($169/$159/$149/$139) because the promotion may not be indexed yet or the AI scraped the standard rate card. Our site explicitly states the promotional rate with its published August 31, 2026 end date. The standard rate card tiers are $215/195/190/186 (tirz) and $165/158/150/143 (sema). Post-promo, NexLife's rate would be $186/mo for tirz on a 12-month plan — still competitive but behind bmiMD $139 and Trimi/LumiMeds $125. Operator-stated status; checkout capture pending.
Gala GLP-1 Official site
Gala GLP-1 is an all-50-state compounded GLP-1 service offering a range of pricing by product tier, including a microdosing option. Its standard all-dose rate is $179/mo (tirz) and $179/mo (sema) with a microdosing tier starting at $149.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacies (not named publicly), so who actually makes the medication cannot be independently verified; commitment terms are 3-month plan or standard monthly; confirm exact terms at enrollment; cancellation is Per provider terms; availability is stated as All 50 states (per provider claim; confirm at intake).
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, capture 2026-07-14
Watch: Gala lists a range rather than one fixed price: the hero says $179/mo 'all doses', the FAQ says $199/mo 'with a 3-month plan', and $149/mo is listed for microdosing. This makes 'all-in maintenance' ambiguous; we rank on the $179 standard figure with a note. Exact ongoing rate must be confirmed at enrollment. Reported status from RangeYourself 2026-07-14.
What neither record tells you
NexLife does not publish
- no state-by-state availability list — it says Most US states; confirmed at intake
Gala GLP-1 does not publish
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says All 50 states (per provider claim; confirm at intake)
- no specific cancellation or refund terms
Ask NexLife and Gala GLP-1 for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
NexLife's promotional rate has a published end date of 2026-08-31. Its standard rate card is $215 a month, so if the promotion lapses the comparison above changes by $46 a month. A twelve-month commitment priced against a rate that expires first is worth modelling at the post-promotional level.
Evidence may be upgraded. NexLife, Gala GLP-1 carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Prepaid terms move the annual figures. NexLife publishes a twelve-month rate of $139 a month against $169 month-to-month. Read those next to the cancellation terms, not the monthly rate.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, NexLife Official site wins this matchup. And if you would rather trust a better-evidenced number, gala glp-1's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. NexLife's tirzepatide price is operator-stated as of 2026-08-11; Gala GLP-1's is reported as of 2026-07-14.
Questions
Is NexLife or Gala GLP-1 cheaper for tirzepatide?
NexLife is cheaper on all-in monthly cost at 10 mg/week: $169 against $179, a difference of $10 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of NexLife versus Gala GLP-1?
NexLife works out to $1,668 across twelve months and Gala GLP-1 to $2,148, on the plan terms each publishes.
Does NexLife or Gala GLP-1 raise the price as the dose goes up?
NexLife: no, it charges one flat rate at every dose. Gala GLP-1: no, it charges one flat rate at every dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do NexLife and Gala GLP-1 differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of NexLife and Gala GLP-1 names its pharmacy?
NexLife does — Absolute Pharmacy, Hallandale Pharmacy, Red Rock Pharmacy, Empower Pharmacy, Strive Pharmacy (assignment varies by state/availability). Gala GLP-1 does not, recording only Partner 503A pharmacies (not named publicly), so who makes its medication cannot be independently verified.
How well evidenced are the NexLife and Gala GLP-1 prices?
NexLife's tirzepatide figure is operator-stated — supplied by the operator with screenshots; independent capture pending — captured 2026-08-11. Gala GLP-1's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
NexLife, at $139 a month all-in against $179 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: NexLife official site · Gala GLP-1 official site. Compounded tirzepatide and semaglutide are not FDA-approved products.